Moreover, CTT has been found to induce robust and sustained CD4+ Th1-dominant systematic antitumor immunity in mouse tumor models and patients with colorectal cancer liver metastasis (CRCLM) 6, 9, 10, 34, 35. The gene discussed is CD4; the disease is neoplasm.